Generic Drug Analysis & Statistics, January 2013 (p40)

Belarus Generic Drug Sales, Us$bn

$ 250
Industry data
January 2013

Yearly, From 2005 To 2022
By Business Monitor International
Source: "Association of International Pharmaceutical Manufacturers in Russia and Research Marketing &

Industries : Generic Drug
Countries : Belarus, Russian Federation

Czech Republic Generic Drug Sales, Us$bn

$ 250
Industry data
January 2013

Yearly, From 2004 To 2021
By Business Monitor International
Source: State Institute for Drug Control (SUKL), Association of the European Self-Medication Industry (AESGP

Industries : Generic Drug
Countries : Czech Republic

China Generic Drug Sales, Us$bn

$ 250
Industry data
January 2013

Yearly, From 2004 To 2021
By Business Monitor International
Source: Southern Medicine Economic Institute (SMEI), Association of the European Self-Medication Society (AE

Industries : Generic Drug
Countries : China

Egypt Generic Drug Sales, Us$bn

$ 250
Industry data
January 2013

Yearly, From 2003 To 2021
By Business Monitor International
Source: Ministry Of Health, local news sources, domestic companies, BMI

Industries : Generic Drug
Countries : Egypt

Bahrain Generic Drug Sales, Us$bn

$ 250
Industry data
January 2013

Yearly, From 2009 To 2021
By Business Monitor International
Source: BMI

Industries : Generic Drug
Countries : Bahrain

United Arab Emirates Generic Drug Sales, Us$bn

$ 250
Industry data
January 2013

Yearly, From 2003 To 2021
By Business Monitor International
Source: BMI

Industries : Generic Drug
Countries : United Arab Emirates

Number Of Approvals Of Registration-drug_clinical Trials Of Generic Drug-china-annual, In Unit (units)

$ 250
Industry data
May 2013

Yearly, From 2006 To 2010
By Chinascope Financial
Source: Chinascope Financial

Industries : Generic Drug

Belgium Generic Drug Sales, Us$bn

$ 250
Industry data
January 2013

Yearly, From 2003 To 2021
By Business Monitor International
Source: Ministry of Health, National Bureau of Statistics, Association of the European Self-Medication Indus

Industries : Generic Drug
Countries : Belgium

Australia Generic Drug Sales, Us$bn

$ 250
Industry data
January 2013

Yearly, From 2004 To 2021
By Business Monitor International
Source: IMS Health, Organisation for Economic Co-operation and Development (OECD), BMI

Industries : Generic Drug
Countries : Australia

Number Of Approvals Of Registration-drug_generic Drug Production-china-annual, In Unit (units)

$ 250
Industry data
May 2013

Yearly, From 2006 To 2010
By Chinascope Financial
Source: Chinascope Financial

Industries : Generic Drug

Turkey Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

$ 1 088
Industry report
December 2012
by Business Monitor International

BMI View: Turkey's pharmaceutical industry offers strong growth potential and will continue to be viewed as an attractive industry for foreign drugmakers, particularly those who are interested in the take ...

Industries : Generic Drug
Countries : Turkey, Syrian Arab Republic

Italy Pharmaceutical Market Overview - Challenging outlook due to austerity and falling birth rate

$ 5 700
Industry report
December 2012
by Datamonitor

High national debt and a falling birth rate create a poor economic outlook and challenging market environment for pharma companies in Italy. Generic penetration is among the lowest in the world. However, ...

Industries : Generic Drug
Countries : Italy

Apotex, Inc.: Pharmaceuticals and Healthcare Company Profile, SWOT and Financial Report

$ 125
Company report
November 2012
by ICD Research

Synopsis ICD Research's "Apotex, Inc.: Pharmaceuticals and Healthcare - Company Profile and SWOT Report" contains in depth information and data about the company and its operations. The profile contains ...

Industries : Generic Drug
Countries : Canada, Czech Republic, New Zealand, Australia, Netherlands, Mexico, Poland, Belgium, World, Europe, Oceania, North America, United Kingdom

Mexico Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

$ 1 088
Industry report
November 2012
by Business Monitor International

BMI View: Despite our generally positive outlook for much of Latin America in 2012, we maintain the view that mounting fiscal pressures and a faltering business environment will damage Mexico's attractiveness ...

Industries : Generic Drug
Countries : Mexico

Global Biosimilars Market - Products, Applications and Regulations

$ 4 320
Industry report
November 2012
by Industry Experts

Several of the leading 25 manufacturers of biosimilars have been entrenched in the market, and have the experience of marketing products for the last 5-10 years. On the other hand, several companies' position ...

Industries : Generic Drug
Countries : World, Europe, United States, United Kingdom, Germany, France, Spain, Italy, India, South Korea

Top 198 Generic Pharmaceuticals (Global)

$ 1 523
Industry report
November 2012
by Plimsoll Publishing Ltd UK

This report is an in-depth financial evaluation of the Global Generic Pharmaceuticals. Using the unique Plimsoll method of analysis, each of the largest 198 companies is individually assessed and ranked ...

Industries : Generic Drug
Countries : World

Generic Drugs: World Market 2013-2023

$ 2 492
Industry report
November 2012
by Visiongain

Report Details Your guide to trends and sales potential for generics Where's the generic drugs market heading? Visiongain's updated report gives you revenue predictions to 2023. There you find data, trends, ...

Industries : Generic Drug
Countries : World

PT Kalbe Farma Tbk (Symbol:KLBF) SWOT Analysis, Strategy, Revenues and Profits

$ 250
Company report
November 2012
by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Industries : Generic Drug
Countries : Indonesia, Philippines, Asia

Navamedic ASA (Symbol:NAVA) SWOT Analysis, Strategy, Revenues and Profits

$ 125
Company report
November 2012
by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Industries : Generic Drug
Countries : Norway

Hovid Berhad (Symbol:HOVID) SWOT Analysis, Strategy, Revenues and Profits

$ 250
Company report
November 2012
by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Industries : Generic Drug
Countries : Malaysia

Balkanpharma - Razgrad AD (Bulgaria) - Company Profile

$ 192
Company report
November 2012
by SeeNews - Research & Profiles

Balkanpharma-RazgradAD is the leading antibiotics producer in Bulgaria and one of the leaders on the Balkan Peninsula. The company exports its products to Australia, Europe, North America and Asia.Balkanpharma ...

Industries : Generic Drug
Countries : Bulgaria

Sintofarm SA (Romania) - Company Profile

$ 192
Company report
November 2012
by SeeNews - Research & Profiles

Sintofarm SA is a Romanian generic drugs producer. The company is in compliance with the Good Manufacturing Practice (GMP) standard since 2004. The company has an ISO 9001:2008 Quality management systems ...

Industries : Generic Drug
Countries : Romania

Europharm SA (Romania) - Company Profile

$ 192
Company report
November 2012
by SeeNews - Research & Profiles

Europharm SA is a leading Romanian generic drugs producer. The company's drug factory in Brasov operates under the Good Manufacturing Practice (GMP) requirements. The company is part of GlaxoSmithKline ...

Industries : Generic Drug
Countries : Romania

Terapia SA (Romania) - Company Profile

$ 192
Company report
November 2012
by SeeNews - Research & Profiles

Terapia SA is the biggest generics drugs producer in Romania.

Industries : Generic Drug
Countries : Romania

Dexcel Pharma - Strategic SWOT Analysis Review

$ 125
Company report
November 2012
by Global Data

Summary Dexcel Pharma (Dexcel) is an Israel-based pharmaceutical company. The company discovers, manufactures and markets generic products. Its portfolio consists of about 55 branded and generic products ...

Industries : Generic Drug
Countries : Israel

Biofarm SA (Romania) - Company Profile

$ 192
Company report
November 2012
by SeeNews - Research & Profiles

Biofarm SA is the leading Romanian generic pharmaceuticals producer. The company meets Good Manufacturing Practice (GMP) requirements. Biofarm SA is listed on the first tier on the Bucharest stock exchange. ...

Industries : Generic Drug
Countries : Romania

Key Pharma Industry Trends through 2014

$ 295
Industry report
November 2012
by Red Mountain Insights

The global pharmaceutical industry has enjoyed steady growth in recent years, despite a global economic downturn. But with patent expiries, stricter regulations, and U.S. healthcare reforms, the pharmaceutical ...

Industries : Generic Drug
Countries : United States

Generic Pharmaceutical Manufacturing Market in the United States

$ 1 020
Industry report
October 2012
by Ibisworld

Introduction The right dose: Emerging industry s and the expiration of major patents will spur growth Description Generic Pharmaceutical Manufacturing in the US Medicine for success: While this growing ...

Industries : Generic Drug
Countries : United States

Key Findings: Spain Pharmaceutical Market Overview

$ 1 910
Industry report
October 2012
by SCRIP Insights

The market environment in Spain is extremely challenging, with cost containment measures introduced in 2010-12 contributing to an overall reduction in pharmaceutical spending. The changes are multi-pronged ...

Industries : Generic Drug
Countries : Spain

Lifecycle Management Strategies: Patent Defense/Litigation - Avoiding anticompetitive settlements and building strong patent estates is key

$ 1 900
Industry report
October 2012
by Datamonitor

When a generics company challenges an innovator-patentee's patent, the most likely outcome is that the innovator either litigates or forms a settlement with the generics company. However, in the latte ...

Industries : Generic Drug
Countries : United States, Europe

Spain Pharmaceutical Market Overview - Continued stagnation as generics and price cuts erode market value

$ 5 700
Industry report
October 2012
by Datamonitor

The market environment in Spain is extremely challenging, with cost containment measures introduced in 2010-12 contributing to an overall reduction in pharmaceutical spending. The changes are multi-pronged ...

Industries : Generic Drug
Countries : Spain

Switzerland Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

$ 1 088
Industry report
October 2012
by Business Monitor International

BMI View: Despite the threat of austerity measures, the Swiss government's focus on cost-containment within the pharmaceuticals and healthcare segment and the impact of generic competition as a result ...

Industries : Generic Drug
Countries : Switzerland

France Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

$ 1 088
Industry report
September 2012
by Business Monitor International

BMI View: France is one of the leading global pharmaceutical industry s by size, propped up by its large population of just under 63mn. The French are traditionally fond of patented and branded drugs and ...

Industries : Generic Drug
Countries : France

Portugal Pharmaceuticals and Healthcare Q4 2012

$ 1 088
Industry report
September 2012
by Business Monitor International

Includes 3 FREE quarterly updates. BMI View: Portugal continues to implement widespread changes to its healthcare sector as part of the EU/IMF/ECB's EUR78bn economic rescue package approved in May 2011, ...

Industries : Generic Drug
Countries : Portugal

Canada Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

$ 1 088
Industry report
September 2012
by Business Monitor International

BMI View: The Canadian pharmaceutical industry continues to be a refuge for leading drugmakers. While we foresee cost constraints hitting the public healthcare system, it is highly unlikely the government ...

Industries : Generic Drug
Countries : Canada

Profound Research and Investment Prospect of China's Generic Drug Market, 2012-2016

$ 1 800
Industry report
August 2012
by Huidian Research

By now, there are more than 10,000 kinds of generic drugs in China, accounting for the vast majority of drug consumption market. There are more and more drug varieties and the quality becomes better and ...

Industries : Generic Drug
Countries : China

EU Biosimilars Database

$ 5 700
Industry report
August 2012
by Datamonitor

Details of all marketed and pipeline biosimilars in the EU. View by product, selecting a molecule name; assess a biosimilar company's pipeline; or view the full pipeline and filter on all 11 labels.Pipeline: ...

Industries : Generic Drug

Generics: World Market Overview (Market size, Segmentation and Trends Analysis)

$ 1 495
Industry report
August 2012
by MarketLine

It includes detailed data on industry size and sector ation, textual analysis of the key trends and competitive landscape, and profiles of the leading firms . This incisive report provides expert analysis ...

Industries : Generic Drug
Countries : World, Europe, United States, United Kingdom, Netherlands, France, Germany, Japan, Canada, Spain, Italy, Belgium, China

India Biosimilar Market Analysis

$ 1 000
Industry report
August 2012
by Kuick Research

As the number of patent expiries of biologic drugs is increasing, Indian companies are developing biosimilar manufacturing capabilities. Firms are developing their capabilities by either forming partnerships ...

Industries : Generic Drug
Countries : India

Intas: Biosimilars Company Analysis

$ 3 800
Company report
July 2012
by Datamonitor

This analysis evaluates the company's strategy and key strengths, weaknesses, opportunities and threats, and provides an overview of the company's biosimilars portfolio, including analysis of key product ...

Industries : Generic Drug
Countries : India